Tobacco Products

Featured

FDA Prevented Up to 587,000 Kids from Trying Cigarettes

By preventing youth from becoming established smokers, “The Real Cost” will save more than $53 billion for youth, their families and society at large.

Proposed Rule: PMTA and Recordkeeping Requirements

FDA’s proposed rule, when final, would set forth requirements related to the content, format, and FDA’s review and communications procedures for premarket tobacco product applications.

Trump Administration Combating Epidemic of Youth E-Cigarette Use

FDA compliance policy would prioritize enforcement of premarket authorization requirements for non-tobacco-flavored e-cigarettes.

Warning Letter to JUUL Labs: Unauthorized Modified Risk Products

FDA warning letter accompanied by request for documents and information about the company’s outreach and marketing practices.

Respiratory Illnesses Associated with Use of Vaping Products

FDA and CDC are working closely with state and local public health partners to investigate incidents of vaping-associated respiratory illnesses as quickly as possible.

Proposed Rule: Required Warnings for Cigarettes Packages and Advertisements

FDA proposes new health warnings with color images for cigarette packages and advertisements to promote greater public understanding of the negative health consequences of smoking.

October 28-29, 2019: Public Meeting – Deemed Tobacco Product Applications

This meeting is intended to provide information on the agency’s expectations for tobacco product applications with a particular focus on deemed tobacco products.

Products, Guidance & Regulations

FDA's approach to regulating tobacco products is grounded in science and uses the full power of the law to protect public health.

Compliance, Enforcement & Training

FDA vigorously enforces the Tobacco Control Act (TCA), which provides FDA with a wide array of powerful regulatory tools to protect the health of all American families.

Newsroom

From press releases to public meetings to email newsletters, stay up to date on the latest news and events from the FDA Center for Tobacco Products.

Public Health Education

While there has been significant progress in educating the public about the dangers of tobacco use, it still remains the leading cause of preventable death in the United States.

Science & Research

FDA supports science and research to help us better understand tobacco use and associated risks so that we can reduce the public health burden of tobacco in the United States.

About the Center for Tobacco Products

FDA's Center for Tobacco Products (CTP) regulates the manufacturing, marketing, and distribution of tobacco products.

Small Businesses Manufacturers Retailers Researchers

FDA's Youth Tobacco Prevention Plan

FDA's Youth Tobacco Prevention Plan—a key component of the agency's Comprehensive Plan for Tobacco and Nicotine Regulation—is a series of actions to stop youth use of tobacco products, especially e-cigarettes. This includes a special focus on preventing youth access to tobacco products, curbing marketing of tobacco products aimed at youth; and educating teens about the dangers of using any tobacco product, including e-cigarettes, as well as educating retailers about their key role in protecting youth.

Learn More

Food and Drug Administration at White Oak

Contact CTP

1-877-287-1373 (9am EST-4pm EST)
For General Inquiries: AskCTP@fda.hhs.gov

Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002

Learn More